TREACE MED CONCEPTS INC shareholders Q2 2024

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 125 filers reported holding TREACE MED CONCEPTS INC in Q2 2024. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

TREACE MED CONCEPTS INC shareholders Q2 2024
NameSharesValueWeighting ↓
US BANCORP \DE\ 680$4,5220.00%
Swiss National Bank 90,900$604,4850.00%
BANK OF AMERICA CORP /DE/ 147,885$983,4370.00%
WELLS FARGO & COMPANY/MN 19,215$127,7800.00%
JANE STREET GROUP, LLC 81,254$540,3390.00%
Avior Wealth Management, LLC 24$1590.00%
NORTHERN TRUST CORP 380,705$2,531,6880.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 40,019$266,1260.00%
Legal & General Group Plc 41,683$277,1920.00%
PRICE T ROWE ASSOCIATES INC /MD/ 15,604$1040.00%
NEW YORK STATE COMMON RETIREMENT FUND 19,081$1270.00%
STRS OHIO 10,600$70,4900.00%
CITIGROUP INC 17,499$116,3690.00%
ROTHSCHILD INVESTMENT LLC 20$1330.00%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 132,869$883,5810.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 373,250$2,482,1130.00%
OSAIC HOLDINGS, INC. 3,339$22,2040.00%
Parallel Advisors, LLC 145$9640.00%
ALLIANCEBERNSTEIN L.P. 75,130$499,6150.00%
External links

This page lists TREACE MED CONCEPTS INC's shareholders in Q2 2024. To view TREACE MED CONCEPTS INC's shareholder history, click here.